title: New therapeutic approaches in sepsis: a critical review.
authors.affiliation: Department of Anesthesiology/Critical Care Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
authors.forename: L A
authors.initials: LA
authors.lastname: Eidelman
authors.forename: R
authors.initials: R
authors.lastname: Pizov
authors.forename: C L
authors.initials: CL
authors.lastname: Sprung
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004311:Double-Blind Method; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D053590:Interleukin 1 Receptor Antagonist Protein; D016032:Randomized Controlled Trials as Topic; D018805:Sepsis / Q000628:therapy*; D012795:Sialoglycoproteins / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; C507763:IL1RN protein, human; D007136:Immunoglobulins; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins; D014409:Tumor Necrosis Factor-alpha; C042866:antilipopolysaccharide antibodies